BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26924048)

  • 21. Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients.
    Yamamoto T; Shoji S; Yamakawa T; Wada A; Suzuki K; Iseki K; Tsubakihara Y
    Am J Kidney Dis; 2015 Sep; 66(3):469-78. PubMed ID: 26015276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
    Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
    Trials; 2013 Jul; 14():196. PubMed ID: 23826760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bicarbonate versus acetate hemodialysis: effects on the acid-base status].
    Avdic E; Suljevic E; Helac-Cvijetic D
    Med Arh; 2001; 55(4):231-3. PubMed ID: 11769453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acid-base balance in haemodialyzed patients].
    Hrabcáková P; Mydlík M; Molcányiová A
    Vnitr Lek; 2002 Oct; 48(10):959-61. PubMed ID: 16737145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bicarbonate: From physiology to treatment for all clinicians].
    Beaume J; Braconnier A; Dolley-Hitze T; Bertocchio JP
    Nephrol Ther; 2018 Feb; 14(1):13-23. PubMed ID: 29150416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approach to the hemodialysis patient with an abnormal serum bicarbonate concentration.
    Lisawat P; Gennari FJ
    Am J Kidney Dis; 2014 Jul; 64(1):151-5. PubMed ID: 24731739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.
    Smith WB; Gibson S; Newman GE; Hendon KS; Askelson M; Zhao J; Hantash J; Flanagan B; Larkin JW; Usvyat LA; Thadhani RI; Maddux FW
    BMC Nephrol; 2017 Aug; 18(1):273. PubMed ID: 28851317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction.
    McLean AG; Davenport A; Cox D; Sweny P
    Kidney Int; 2000 Oct; 58(4):1765-72. PubMed ID: 11012911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
    Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
    Trials; 2015 Aug; 16():326. PubMed ID: 26231610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit of bicarbonate dialysis during CAVHD.
    Jenkins RD; Jackson E; Kuhn R; Funk J
    ASAIO Trans; 1990; 36(3):M465-6. PubMed ID: 2252728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to achieve optimal correction of acidosis in end-stage renal failure patients.
    Zucchelli P; Santoro A
    Blood Purif; 1995; 13(6):375-84. PubMed ID: 8821203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic acidosis in chronic kidney disease].
    Havlín J; Matoušovic K; Vaňková S; Schück O
    Vnitr Lek; 2016; 62 Suppl 6():30-39. PubMed ID: 28124929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study.
    Schmaderer C; Braunisch MC; Suttmann Y; Lorenz G; Pham D; Haller B; Angermann S; Matschkal J; Renders L; Baumann M; Braun JR; Heemann U; Küchle C
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Severe metabolic alkalosis during hemodialysis].
    Asensio Sánchez MJ; del Pozo Hernando LJ; Asensio Sánchez VM; Martínez Díaz A; del Villar Sordo V
    An Med Interna; 1991 Apr; 8(4):179-80. PubMed ID: 1912171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unsuspected cause for metabolic acidosis in chronic renal failure: sorbent system hemodialysis.
    Brezis M; Brown RS
    Am J Kidney Dis; 1985 Dec; 6(6):425-7. PubMed ID: 4073022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of Acid-Base Derangements in CKD.
    Chen W; Abramowitz MK
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):280-288. PubMed ID: 29031354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact of dialysis on the acid-base balance].
    Marano M
    G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High bicarbonate dialysate in haemodialysis patients: effects on acidosis and nutritional status.
    Williams AJ; Dittmer ID; McArley A; Clarke J
    Nephrol Dial Transplant; 1997 Dec; 12(12):2633-7. PubMed ID: 9430864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic haemodialysis with bicarbonate dialysate. Technical and clinical aspects.
    Leunissen KM; Claessens PJ; Mooy JM; van Hooff JP; Shaldon S
    Blood Purif; 1990; 8(6):347-58. PubMed ID: 2093332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.